Jazz Pharmaceuticals plc JAZZ Cash Flow

Jazz pharmaceuticals plc (JAZZ)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities
Net income (loss)
280,333	523,367	608,845	655,885	486,308	447,098	519,835	434,045	447,328	487,848	372,330	398,632	407,530	396,831	362,903	361,035	334,646	329,534	328,384	266,192	221,665	57,326	31,008	80,649	79,248	216,312	361,570	319,370	304,330	288,586	125,508	124,781	130,838	124,984	0	0	0
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Intangible asset amortization
360,776	354,814	227,867	211,993	205,376	201,498	207,856	208,180	179,407	152,065	125,326	104,466	105,017	101,994	99,522	99,196	96,127	98,162	106,449	110,952	120,079	126,584	115,131	104,065	90,669	79,042	80,426	82,612	78,964	72,922	52,876	32,988	19,099	7,448	0	0	0
Share-based compensation
111,665	110,563	111,349	107,667	105,690	102,441	103,039	105,062	106,010	106,900	103,860	101,608	99,781	98,771	98,807	97,047	94,914	91,550	86,253	81,390	76,642	69,638	63,030	56,655	49,609	44,551	39,994	34,730	28,482	23,006	26,097	22,680	20,837	20,704	0	0	0
Impairment charge
136,139	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation
16,330	15,342	14,755	14,670	15,050	15,233	15,164	14,323	13,681	13,089	12,909	12,965	12,389	11,786	10,916	10,343	10,189	9,894	9,203	8,523	8,020	7,097	6,020	5,047	3,782	3,048	2,583	2,062	1,696	1,307	900	605	461	379	0	0	0
Acquired in-process research and development
256,225	109,975	109,975	58,200	56,000	0	0	0	0	-	-	-	-	23,750	23,750	8,750	8,750	0	626	75,626	75,626	202,626	202,000	127,988	127,988	4,988	0	0	0	-	-	-	-	-	-	-	-
Loss on disposal of assets
-91	-21	-11	-547	-402	-655	-765	-131	-647	-473	-404	-467	-92	-47	-58	-163	-201	-172	-141	-70	-30	-24	1	-6	-8	-46	-64	-64	-203	-163	0	0	0	-	-	-	-
Acquisition accounting inventory fair value step-up adjustments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,477	11,160	11,672	10,303	3,826	5,260	16,190	19,115	19,939	0	0	0	-	-	-	-
Excess tax benefit from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	3,993	792	4,888	0	5,601	3,547	8,760	9,785	0	0	0	-	-	-	-
Change in fair value of contingent consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15,200	-11,500	-7,400	-4,200	300	0	0	0	-	-	-	-
Deferred tax benefit
-283,533	-236,610	-212,092	-207,934	-90,561	-88,815	-216,890	-227,863	-225,898	-225,591	-65,249	-61,007	-50,421	-41,163	-72,263	-61,597	-64,839	-68,358	-38,376	-47,529	-54,137	-49,254	-28,381	-19,631	-10,601	-10,097	-123,056	-122,926	-117,736	-113,862	0	0	0	-	-	-	-
Provision for losses on accounts receivable and inventory
8,760	6,668	3,841	4,461	4,666	4,728	5,099	3,312	1,832	2,190	2,270	2,069	2,259	2,209	1,805	5,140	4,534	4,062	3,641	1,178	2,106	2,493	3,561	3,135	3,117	2,446	3,716	5,873	4,753	4,654	0	0	0	-	-	-	-
Amortization of debt discount and deferred financing costs
47,263	46,396	45,706	45,040	44,476	43,960	43,461	40,151	35,028	30,026	24,949	22,736	22,386	22,133	21,808	21,466	22,084	22,738	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Other non-cash transactions
1,411	4,051	6,908	9,044	12,265	-4,499	-6,811	-17,317	-28,942	-14,321	-9,279	-3,292	3,915	3,741	-107	110	-1,776	5,187	8,438	19,003	19,238	11,986	10,130	-1,343	-1,580	-1,687	0	0	0	-	-	-	-	-394	0	0	0
Changes in assets and liabilities:
Accounts receivable
-2,495	92,326	-11,079	33,350	40,501	40,132	20,967	39,040	35,830	-12,278	19,602	6,483	20,284	25,603	42,454	38,520	33,874	24,841	15,012	41,631	43,796	55,041	61,887	31,720	45,949	48,846	24,600	36,312	14,841	4,724	20,719	16,802	21,785	12,293	0	0	0
Inventories
34,337	32,790	33,957	28,136	23,888	18,512	9,118	11,726	7,721	8,667	10,039	7,853	14,975	17,024	4,251	6,930	-1,806	-6,271	1,041	6,177	6,401	7,630	15,255	5,714	12,818	8,516	3,463	5,196	-3,029	-1,697	-2,306	-1,676	-1,088	-1,239	0	0	0
Prepaid expenses and other current assets
42,505	25,650	23,150	3,964	-9,243	-6,697	9,295	31,272	19,771	26,874	17,778	6,235	25,106	15,700	-506	-7,061	-18,159	-3,720	-2,376	2,676	8,091	-11,936	-1,691	-1,737	3,242	13,871	20,548	22,373	17,146	13,091	3,726	4,504	2,309	934	0	0	0
Other non-current assets
14,933	14,830	-2,175	1,393	906	320	-1,700	-4,153	-3,301	-119	1,855	1,753	2,007	-267	-5,279	-1,838	1,191	4,573	6,840	6,353	4,793	3,060	6,660	5,054	4,852	4,306	4,615	5,754	4,192	3,491	0	0	0	-	-	-	-
Operating lease assets
-15,235	-14,148	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets and liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Accounts payable
22,820	4,770	36,028	-4,427	-4,542	17,040	4,200	2,238	17,485	214	10,779	-516	-4,438	361	-11,394	1,815	5,081	-2,280	725	-4,282	-43,242	-37,966	-35,446	-31,173	-2,490	5,089	1,927	-13,942	4,223	-7,286	-5,877	11,827	6,130	2,080	0	0	0
Accrued liabilities
-14,033	-5,565	-31,235	-47,931	19,994	71,208	82,079	86,602	56,649	-6,578	-3,802	-17,349	2,952	11,989	-9,448	17,387	13,765	2,986	6,171	3,683	2,585	20,997	32,623	21,645	18,304	14,717	5,946	-29,948	-7,549	-11,428	-16,863	18,841	4,970	11,211	0	0	0
Income taxes payable
-8,841	10,056	37,077	12,600	5,808	-19,735	-6,163	10,559	-239	16,331	8,134	2,051	7,957	2,962	-11,941	-9,370	-10,676	-6,271	-1,376	9,677	33,040	8,634	-895	-11,632	-31,830	-38,984	-7,885	11,874	37,943	39,340	0	0	0	-	-	-	-
Deferred revenue
-4,720	-5,414	-6,108	-6,802	-7,496	-7,497	-7,777	-8,060	-8,356	21,009	22,530	24,481	26,441	-1,315	-559	-630	-517	-536	-944	-1,028	-1,215	-1,203	-1,203	-1,126	-1,127	-1,061	-1,933	-1,947	-1,127	-1,205	-332	-547	-1,561	-1,273	0	0	0
Contingent consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14,900	-14,900	-14,900	-14,900	0	0	0	0	-	-	-	-	-	-	-	-
Other non-current liabilities
4,104	3,561	3,659	14,759	13,659	14,537	13,247	17,356	18,411	18,934	17,778	24,145	23,981	23,199	26,445	27,878	27,134	26,562	23,283	22,534	19,855	17,724	17,605	16,572	16,313	14,820	12,777	9,897	5,548	2,351	0	0	0	-	-	-	-
Operating lease liabilities, less current portion
-10,806	-6,044	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liability under government settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7,320	-7,225	-7,130	-8,202	-3,786	0	0	0
Net cash provided by operating activities
847,117	776,401	906,699	790,671	833,798	798,904	785,367	752,789	695,906	693,087	669,223	613,354	605,277	592,391	531,437	573,485	587,042	531,943	546,464	501,085	435,438	407,606	352,378	353,469	287,264	288,431	313,742	227,097	295,347	249,752	189,066	190,976	151,443	151,596	0	0	0
Investing activities
Proceeds from maturity of investments
985,000	985,000	1,110,000	1,100,000	1,005,000	855,000	645,000	515,000	365,000	230,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property, plant and equipment
37,017	40,135	38,147	31,000	21,169	20,370	24,099	28,506	32,525	28,950	21,349	15,384	10,789	9,687	11,777	14,554	24,020	35,958	46,139	49,119	47,230	36,347	25,901	19,926	12,360	9,976	7,857	8,192	6,834	5,976	5,749	3,612	1,498	1,279	0	0	0
Acquired in-process research and development
207,950	61,700	61,700	58,200	56,000	0	0	0	0	-	-	-	-	23,750	23,750	8,750	8,750	0	626	75,626	77,626	202,626	202,000	127,988	125,988	4,988	0	0	0	-	-	-	-	-	-	-	-
Asset acquisition, net of cash acquired
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	828,676	828,676	828,676	828,676	0	0	0	624,282	542,531	0	0	0	-	-	-	-
Proceeds from sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	81,246	0	0	0	-	-	-	-
Proceeds from maturities of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31,988	0	0	0	-	-	-	-
Acquisition of intangible assets
93,500	80,500	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,300	1,300	1,300	1,300	0	-3,375	-2,250	-1,125	0	0	0	0
Acquisition of investments
987,100	917,100	830,640	1,021,540	1,040,915	1,165,915	1,016,250	770,350	565,000	385,000	346,277	198,697	191,408	132,181	75,904	53,484	773	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from sale of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	33,703	33,703	33,703	32,703	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37,443	0	0	0	-	-	-	-
Purchase of product rights
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16,500	0	0	0	-	-	-	-
Net cash (used in) provided by investing activities
-381,432	-155,300	43,745	11,660	-176,286	-394,487	-466,357	-477,958	-317,525	-268,950	-238,931	-1,566,618	-1,742,734	-1,751,155	-1,752,663	-226,788	-32,543	-2,255	-13,062	-91,042	-92,153	-1,067,649	-1,056,577	-976,590	-967,024	-16,264	74,027	73,430	-484,245	-395,294	-548,082	-557,955	2,467	-81,232	0	0	0
Financing activities
Proceeds from employee equity incentive and purchase plans
68,038	57,831	35,371	42,401	85,806	93,337	93,087	79,811	36,736	31,824	29,016	28,634	26,070	24,174	24,449	28,404	30,799	40,523	44,060	53,575	50,524	58,487	55,578	46,882	42,561	30,703	27,585	21,893	29,452	25,003	0	0	0	-	-	-	-
Payment of contingent consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35,100	35,100	35,100	35,100	0	0	0	0	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Payment of employee withholding taxes related to share-based awards
16,476	16,739	16,633	16,715	17,141	17,925	17,872	18,292	18,752	18,589	18,548	23,276	23,189	21,234	21,295	23,701	23,800	26,102	26,126	24,158	23,445	18,030	17,593	14,544	13,526	5,590	5,303	1,597	1,427	25,299	0	0	0	-	-	-	-
Repayments of long-term debt
33,387	33,387	33,387	33,387	25,041	25,717	26,394	27,070	36,094	36,094	36,092	27,069	27,930	28,304	28,679	29,640	912,873	905,760	898,797	900,122	9,509	9,524	8,483	7,590	462,271	465,910	470,454	474,999	17,813	11,875	5,938	33,336	37,502	41,668	0	0	0
Share repurchases
329,254	301,450	637,772	639,229	600,375	523,672	119,389	123,501	119,449	98,799	74,902	145,911	157,827	278,296	300,070	213,107	185,580	61,553	33,544	30,418	52,553	42,215	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of Lines of Credit
-	-	-	-	-	-	-	-	-	850,000	1,000,000	500,000	300,000	150,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7,350	0	0	0
Net proceeds from issuance of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,194,385	1,195,366	636,355	1,189,780	553,425	0	0	0	-	-	-	-	-	-	-	-
Excess tax benefit from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	3,993	792	4,888	0	5,601	3,547	8,760	9,785	0	0	0	-	-	-	-
Acquisition of noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	136,969	136,950	136,640	119,175	0	0	0	0	-	-	-	-	-	-	-	-
Net cash used in financing activities
-311,079	-293,745	-652,421	-646,930	-561,904	-479,130	-72,658	-31,658	-275,012	-409,111	-541,172	327,025	511,771	540,987	589,171	-400,478	-363,520	-214,323	-100,902	256,789	210,111	711,034	692,751	383,762	470,673	-23,856	8,457	48,691	469,888	448,530	447,741	419,617	-48,317	-33,082	0	0	0
Effect of exchange rates on cash and cash equivalents
-470	366	-1,866	-2,743	-1,311	-1,700	51	2,695	2,805	5,046	-3,072	-2,514	-7,099	-5,045	-237	104	6,198	-10,622	-8,681	-13,444	-16,667	-3,453	-1,974	3,307	4,450	997	2,443	546	-1,133	2,132	0	0	0	-	-	-	-
Net increase in cash and cash equivalents
154,136	327,722	296,157	152,658	94,297	-76,413	246,403	245,868	106,174	20,072	-113,952	-628,753	-632,785	-622,822	-632,292	-53,677	197,177	304,743	423,819	653,388	536,729	47,538	-13,422	-236,052	-204,637	249,308	398,669	349,764	279,857	305,120	88,578	52,147	105,593	37,282	0	0	0